USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:27 PM 2012

NYSE 8090.51 7.53 Index Moved Up

NASDAQ 2929.04 13.18 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and MTEX...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

Mannatech Incorporated

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Mannatech Incorporated in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.03

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Suggest

48.9

Intraday

One Month

^(0.32)

0.65%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	P/B Ratio	6.06
Open	49.47	Day Low	48.80
Market Cap	2.892B	Volume	148420
Last Close	49.22	Short Ratio	7.80
Last Traded	2/9/2012	Year High	50.28
Percent Change	0.65%	EBITDA	142.7M
Year Low	25.64	Absolute Change	0.32
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Day High	49.8084
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

Illumina's Board Unanimously Rejects Roche's Offer; Shire Announces FDA ...

BioMedReports (subscription) - Feb 8, 2012

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

2012-02-07

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation ...

MarketWatch (press release) - Feb 7, 2012

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals Announces FDA Priority Review Designation for Crofelemer NDA
- NCTechNews (press release)

2012-02-07

Salix Pharmaceuticals Announces FDA Granting Of Priority Review Designation For Crofelemer NDA For Treatment Of Diarrhea

Reuters Key Development - Feb 7, 2012

2012-02-07

Salix Pharmaceuticals Crosses Above its 10-day MA (SLXP)

Financial News Network Online - Jan 31, 2012

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

2012-01-31

Salix Scores with Oral Relistor

2011-12-27

Salix Pharmaceuticals (SLXP): Zacks Rank Buy

2011-12-19

Zacks Bull and Bear of the Day Highlights: Salix Pharmaceuticals, Montpelier Re Holdings, Wal-Mart, Macy's and Best Buy

2011-11-28

4.5

Intraday

One Month

^0.06

1.35%

MTEX

NASDAQ

Mannatech Incorporated

P/B Ratio	0.41	Open	4.52
Day Low	4.48	Market Cap	11.9M
Volume	1030	Last Close	4.44
Short Ratio	55.60	Last Traded	2/9/2012
Year High	21.50	Percent Change	1.35%
EBITDA	-2.5M	Year Low	3.80
Absolute Change	0.06	Time	Not Applicable
Book Value	10.711	EPS	-6.20
Day High	4.52	Target Price	20.00
Current EPS	-6.20	This Year EPS	Not Applicable
Dividend Date	29-Jun-09

MANNATECH, INC.: TWU's Nutrition and Personal Health Coaching Certificatio..

4-traders (press release) - Feb 1, 2012

It's official. Mannatech, Incorporated (NASDAQ: MTEX), the provider of nutritional supplements and skin care products based on Real Food Technology ? solutions, and the Texas Woman's University (TWU) announced that the very first online classes for ...

2012-02-01

NTRR Moves Forward with Manufacture of New Pure Plus Supplement

EON: Enhanced Online News (press release) - Jan 31, 2012

TAMPA, Fla.--(EON: Enhanced Online News)--Neutra Corp. (OTCBB: NTRR), an emerging provider of innovative nutraceuticals, announced today that it is one step closer to delivering its revolutionary Pure Plus weight-loss supplement to market.

2012-01-30

Thursday 1/19 Insider Buying Report: MTEX, FDI

MarketNewsVideo.com - Jan 19, 2012

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, ...

2012-01-19

NTRR Names New Weight-Loss Supplement 'Pure Plus'

TheStreet.com (press release) - Jan 19, 2012

By Business Wire 01/19/12 - 05:00 AM EST Pure Plus will be the name of the new all-natural weight-loss supplement currently being developed by Neutra Corp.

2012-01-19